Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL522619 | 0.84 | ACHE (0.43) | ACHENPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL523766 | 0.84 | ACHE (0.43) | ACHETAAR1CYP4F2CYP4A11KIF11 | |
| SCHEMBL15545063 | 0.80 | CNR1 (0.35) | TAAR1 | |
| SCHEMBL17414237 | 0.80 | ALDH1A1 (0.39) | HPGDSMN1; SMN2RECQLTAAR1 | |
| SCHEMBL15814084 | 0.80 | ACHE (0.37) | ACHEACLYNPC1RAB9AHPGD | |
| SCHEMBL17414230 | 0.80 | ACHE (0.37) | ACHEACLYNPC1RAB9AHPGD | |
| SCHEMBL29738548 | 0.80 | ACHE (0.37) | ACHEACLYNPC1RAB9AHPGD | |
| SCHEMBL4681948 | 0.78 | TAAR1 (0.48) | ACHENPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL23287117 | 0.77 | NMT1 (0.32) | ACLYRECQLTAAR1 | |
| SCHEMBL15545176 | 0.77 | L3MBTL1 (0.33) | ACLYNPC1RAB9ASMN1; SMN2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1226258-C | Process for producing fluorinated methyl-benzyl alcohol | SHOWAN DENKO K K (JP) | 2005-11-09 | — | — | CN | disclosed |
| US-6828467-B2 | Industrial process of the hydrogenolysis of one hydroxyl or methanol group of a fluorinated benzenedimethanol carried out in a solvent in the presence of a catalyst; 2,3,5,6-tetra-fluorobenzyl alcohol from the 4-methyl derivative | SHOWA DENKO K.K. (JP) | 2004-12-07 | — | — | US | disclosed |
| EP-1322584-B1 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | SHOWA DENKO K.K. (JP) | 2004-01-15 | — | — | US | disclosed |
| CN-1466560-A | Process for producing fluorinated methyl-benzyl alcohol | �Ѻ͵繤��ʽ���� | 2004-01-07 | — | — | CN | disclosed |
| EP-1322584-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | Showa Denko K.K. (JP) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002026678-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | ADH1C, ADH5, ADH1A | ACHE 2586/4885ACLY 4764/4885NPC1 2185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.